Reto Schwendener received his B.S. degree in pharmacy in 1975 and his Ph.D. degree in physical pharmacy in 1979 from the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. Since 1998, he has been a Professor of clinical pharmacy and the Head of the Laboratory of Liposome Research. After postdoctoral training at the University of California at Davis and the Argonne National Laboratory (1981-1982), he assumed the following positions as an Assistant Professor at the Institute of Pharmacy and Biopharmacy, ETH, Zurich (1983-1984); at the University Hospital Zurich: Department of Pathology (1985–1988), Department of Radiology (1989-1990), Department of Internal Medecine (1991–1995), and Department of Pathology (1996–2000); and at the Paul Scherrer Institute (2000–2006). Since 2006, he has been at the Institute of Molecular Cancer Research at the University of Zurich. In 1995, he received the Dr. Th. Jucker Award of the University Zurich. Professor Schwendener is an expert of drug delivery and delivery systems and prodrug design and synthesis of lipophilic anticancer and antiviral drugs that can be incorporated in liposomes. More recently, he focuses on the depletion of macrophages with bisphosphonate-liposomes (clodrolip) for immunological studies and as adjuvant cancer therapy. In addition, he has been a pioneer in the development of scale-up techniques for liposomes which were used for large-scale preclinical and clinical studies and has published over 130 research articles, book chapters, and patents. He has lectured extensively both in Europe and the United States. His research is sponsored by the Swiss National Science Foundation and the Swiss Federal Office of Health, and various other private foundations and pharmaceutical companies.
Biography Updated on 30 January 2012